Skip to main content
. 2017 Dec 20;6(12):e005965. doi: 10.1161/JAHA.117.005965

Table 1.

Electrocardiographic Parameters Derived From ECG Traces of Rat Groups

Group Heart Rate (bpm) P Duration (ms) PR Interval (ms) QRS Duration (ms) QT Interval (ms) QTc Interval (ms)
Control 290 (262–300) 20.59 (19.60–22.08) 55.05 (52.75–56.34) 21.26 (20.62–22.47) 68.77 (60.19–73.16) 140.60 (132.10–158.40)
CHF+SE siRNA 346 (321–368) 24.91 (10.16–42.12) 53.11 (47.24–58.75) 24.53 (17.00–28.50) 98.46 (92.35–109.60) 232.62 (216.20–250.50)
CHF+SE 328 (320–336)a 18.17 (16.25–20.98) 52.64 (51.56–54.14) 21.57 (19.65–22.50) 79.33 (73.07–88.46)a 184.40 (177.50–188.30)a
CHF 352 (315–383)b 22.94 (12.16–35.38) 55.85 (43.25–64.30) 26.92 (19.18–30.92) 89.01 (82.55–92.10)b 205.10 (197.40–222.50)b
CHF+EGFP 343 (340–376) 23.98 (14.21–36.88) 56.75 (53.62–60.75) 23.50 (18.50–28.51) 87.92 (80.28–98.14) 203.74 (191.70–233.10)
CHF+AS 372 (335–398)a 31.11 (18.15–43.44) 56.48 (48.62–61.80) 24.50 (16.30–32.40) 95.67 (89.51–106.80)a 230.70 (218.20–237.00)a
CHF+AS siRNA 331 (319–339)a 26.53 (11.07–37.23) 62.85 (53.82–62.60) 19.50 (16.97–26.50) 75.13 (69.68–82.13)a 178.10 (165.40–187.80)a

Data are given as median (25th–75th percentile). AS indicates antisense RNA; bpm, beats/min; CHF, congestive heart failure; EGFP, enhanced green fluorescent protein; QTc, corrected QT; and SE, sense, Kcna2.

a

Significant difference at P<0.05 when compared with the CHF group (n=10).

b

Significant difference at P<0.05 when compared with the control group (n=10).